/Companies

NOVOS

Founded 2018 · 34 employees on LinkedIn · 8 known investors

Find your way into NOVOS

Sign up to see every warm intro you have to NOVOS

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NOVOS team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.

Founders & leadership

NOVOS was founded in 2018 by Chris Mirabile.

CMChris Mirabile
Chris MirabileFounder & CEOChris Mirabile is founder and CEO of NOVOS, a longevity biotechnology company developing supplement formulations and aging assessment tools. He leads a team that includes advisors and researchers from institutions including Harvard and MIT.

Investors · 8

Also in the syndicate · 1

Gal Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does NOVOS do?
NOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
Who founded NOVOS?
NOVOS was founded by Chris Mirabile in 2018.
Who are NOVOS's investors?
NOVOS's investors include Cornucopian Capital Management, Fab Co-Creation Studio Ventures, Resolute Ventures, UNCOMMON DENOMINATOR, Kaedan Capital, MizMaa Ventures, Remagine Ventures.